Kurin, a minority-owned medical device company, was founded with the mission to engineer innovative, cost-effective healthcare solutions. The company focuses on reducing false positive blood cultures, a significant issue in clinical settings. Kurin offers products like the Kurin Lock and Kurin Jet, designed to minimize contamination during blood culture collection. Their market focus includes hospitals and healthcare providers looking to improve diagnostic accuracy and reduce unnecessary costs associated with false positives.
Notable figures affiliated with Kurin include the inventors of Curos™ disinfecting port protectors, which were successfully adopted and acquired by a larger corporation. Kurin has achieved significant milestones, including the development and clinical adoption of their contamination-reducing technologies. The company's impact is evident in its contribution to more accurate blood culture results, leading to better patient outcomes and reduced healthcare costs.
